Literature DB >> 7477541

[Coronary heart disease in the elderly; the ERGO study (Erasmus Rotterdam Health and the Elderly)].

D E Grobbee1, J G van der Bom, M L Bots, M C de Bruijne, A Mosterd, A W Hoes.   

Abstract

OBJECTIVE: To determine the prevalence of cardiovascular disease among elderly people and to investigate the use of cardiovascular medication in this group.
DESIGN: Cross-sectional study.
SETTING: A quarter in Rotterdam, the Netherlands.
METHODS: As a part of the 'Rotterdam elderly study', the cardiovascular anamnesis of 7.983 responding persons > or = 55 years (3105 men and 4878 women) was obtained by means of a questionnaire.
RESULTS: Twelve and 4% of men and women, respectively, had at some time had a myocardial infarction, and 5 and 4% a stroke. Almost 7% of both sexes had anamnestic symptoms of angina pectoris. Coronary bypass surgery and percutaneous transluminal coronary angioplasty were done in 4% and 1% of men and 1% and 0.5% of women, respectively. Of all participants 43% used at least one drug for cardiovascular purposes. Half of these used two or more, and a quarter used three or more drugs. Among women, diuretics were the most commonly used drug for cardiovascular purposes (21%), whereas among men beta-blocking agents were most common (15%).
CONCLUSION: Cardiovascular diseases are common among elderly men and women. Many of them take at least one drug for cardiovascular purposes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477541

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Chest pain and angina pectoris - or the ugly swan and the beautiful duckling.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2010-11       Impact factor: 2.380

2.  The new old epidemic of coronary heart disease.

Authors:  L Bonneux; J J Barendregt; P J van der Maas
Journal:  Am J Public Health       Date:  1999-03       Impact factor: 9.308

3.  Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study.

Authors:  Maarten J G Leening; Maryam Kavousi; Jan Heeringa; Frank J A van Rooij; Jolande Verkroost-van Heemst; Jaap W Deckers; Francesco U S Mattace-Raso; Gijsbertus Ziere; Albert Hofman; Bruno H Ch Stricker; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2012-03-03       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.